Medartis Holding AG (SWX:MED)
Switzerland · Delayed Price · Currency is CHF 82.10
+0.10 (0.12%)
Oct 2, 2026, 5:30 PM CET
Medartis Holding AG Market Cap
Medartis Holding AG has a market cap or net worth of 1.02 billion as of October 2, 2026. Its market cap has decreased by -4.55% in one year.
Market Cap
1.02B
Enterprise Value
1.20B
Revenue
307.05M
Ranking
n/a
PE Ratio
68.39
Stock Price
82.10
ChartMarket Cap Chart
Since March 23, 2018, Medartis Holding AG's market cap has increased from 726.81M to 1.02B, an increase of 40.42%. That is a compound annual growth rate of 4.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 1.02B | -6.90% |
| Dec 30, 2025 | 1.10B | 42.46% |
| Dec 30, 2024 | 769.51M | -25.88% |
| Dec 29, 2023 | 1.04B | 6.78% |
| Dec 30, 2022 | 972.24M | -36.80% |
| Dec 30, 2021 | 1.54B | 180.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 23, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 279.40B |
| Novartis AG | 228.01B |
| Lonza Group AG | 40.17B |
| Galderma Group AG | 38.67B |
| SKAN Group AG | 1.59B |
| PolyPeptide Group AG | 1.46B |
| Aevis Victoria | 1.34B |
| Idorsia | 1.25B |